par Mauer, M;Stupp, R;Taphoorn, M J B;Coens, C;Osoba, D;Marosi, C;Wong, R;De Witte, Olivier ;Cairncross, J G;Efficace, F;Mirimanoff, René Olivier;Forsyth, P;van den Bent, M J;Weller, M;Bottomley, A
Référence British Journal of Cancer, 97, 3, page (302-307)
Publication Publié, 2007-08
Référence British Journal of Cancer, 97, 3, page (302-307)
Publication Publié, 2007-08
Article révisé par les pairs
Titre: |
|
Auteur: | Mauer, M; Stupp, R; Taphoorn, M J B; Coens, C; Osoba, D; Marosi, C; Wong, R; De Witte, Olivier; Cairncross, J G; Efficace, F; Mirimanoff, René Olivier; Forsyth, P; van den Bent, M J; Weller, M; Bottomley, A |
Informations sur la publication: | British Journal of Cancer, 97, 3, page (302-307) |
Statut de publication: | Publié, 2007-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Glioblastoma |
HRQOL scores | |
Prognostic factors | |
MeSH keywords: | Brain Neoplasms -- physiopathology |
Female | |
Glioblastoma -- physiopathology | |
Humans | |
Male | |
Middle Aged | |
Prognosis | |
Prospective Studies | |
Quality of Life | |
Survival Analysis | |
Note générale: | Clinical Trial, Phase III |
Journal Article | |
Randomized Controlled Trial | |
Research Support, N.I.H., Extramural | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0007-0920 |
info:doi/10.1038/sj.bjc.6603876 | |
info:pii/6603876 | |
info:scp/34547574155 | |
info:pmid/17609661 | |
PMC2360328 |